Concepedia

Niya Xiong

NX

Statistics

Publications

24

Citations

1.1K

H-Index

16

Active since

2016

Affiliations

Dana-Farber Cancer Institute(Current)

Massachusetts General Hospital

Brigham and Women's Hospital

Beth Israel Deaconess Medical Center

University of Electronic Science and Technology of China

Niya Xiong is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2016–2024

24

Publications

24

Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma

Joyce F. Liu, Niya Xiong, Susana M. Campos et al. · Journal of Clinical Oncology · 2021 · 195 citations

, , +17

Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis <i>in vivo</i>

Hong Yang, Liu‐Yuan Guan, Shun Li et al. · Oncotarget · 2016 · 144 citations · Full text

, , +17

MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial–mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells

Shun Li, Juan Lü, Yu Chen et al. · Cellular and Molecular Immunology · 2016 · 95 citations · Full text

, , +16

Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial

Elizabeth K. Lee, Niya Xiong, Su–Chun Cheng et al. · Gynecologic Oncology · 2020 · 89 citations

, , +14

A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor–Positive Recurrent Endometrial Cancer

Panagiotis A. Konstantinopoulos, Elizabeth K. Lee, Niya Xiong et al. · Journal of Clinical Oncology · 2022 · 82 citations

, , +17

1–5 of 24